Healthcare - Medical - Devices - NASDAQ - IL
$ 5.85
-2.99 %
$ 342 M
Market Cap
-5.85
P/E
CASH FLOW STATEMENT
-44.8 M
OPERATING CASH FLOW
35.4 M
INVESTING CASH FLOW
27.3 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Nano-X Imaging Ltd.
| Net Income | -60.8 M |
| Depreciation & Amortization | 11.8 M |
| Capital Expenditures | -3.3 M |
| Stock-Based Compensation | 6.84 M |
| Change in Working Capital | -7.48 M |
| Others | -1.61 M |
| Free Cash Flow | -48.1 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||
| Net Income | (60.8) | (105.2) | (61.8) | (43.8) | (22.6) | (1.9) |
| Depreciation & Amortization | 11.8 | 11.5 | 2.3 | 0.2 | 53 K | 35 K |
| Deferred Income Tax | (0.4) | (3.7) | (0.1) | (25.3) | (16.4) | 0 |
| Stock Based Compensation | 6.8 | 18.6 | 18.8 | 24.8 | 16.2 | 0.1 |
| Other Operating Activities | 5.2 | 52.4 | 2 K | 25.3 | 16.4 | 0.2 |
| Change in Working Capital | (7.5) | (16.9) | 2.7 | (2.7) | 0.7 | (1.9) |
| Cash From Operations | (44.8) | (43.4) | (38.1) | (21.5) | (5.5) | (3.7) |
| INVESTING CASH FLOW | ||||||
| Capital Expenditures | (3.3) | (7.2) | (23.2) | (13.9) | (0.1) | 73 K |
| Other Items | 38.7 | 21.8 | (93.2) | 0 | 0 | 0 |
| Cash From Investing Activities | 35.4 | 14.6 | (116.3) | (13.9) | (0.1) | 73 K |
| FINANCING CASH FLOW | ||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 0 | 0 | 3.8 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0.1 | 0.8 | 3.6 | 0.6 | (0.2) | 0 |
| Cash From Financing Activities | 27.3 | 0.8 | 7.4 | 241.0 | 13.9 | 3.7 |
| CHANGE IN CASH | ||||||
| Net Change In Cash | 18.0 | (28.2) | (147.0) | 205.6 | 8.2 | 60 K |
| FREE CASH FLOW | ||||||
| Free Cash Flow | (48.1) | (50.6) | (61.2) | (35.4) | (5.6) | (3.7) |